Search results
Results from the WOW.Com Content Network
Timeline of Gallup polls in US on legalizing marijuana. [1]In the United States, cannabis is legal in 39 of 50 states for medical use and 24 states for recreational use. At the federal level, cannabis is classified as a Schedule I drug under the Controlled Substances Act, determined to have a high potential for abuse and no accepted medical use, prohibiting its use for any purpose. [2]
Illegal since 1965. As of 2022, use and possession of up to 15 g (1 ⁄ 2 oz) are punished with heavy fines and possible loss of driver's license. [189] [190] [191] Solberg's Cabinet proposed a decriminalization bill in 2021 that would remove all sanctions for illegal drug use, including possession of up to 10 g (3 ⁄ 8 oz) of cannabis. Six ...
Was the Department of Health Division of Medical Marijuana and Integrative Therapy until October 1, 2020; [6] medical cannabis only – there is no regulatory agency for other use. [a] Puerto Rico Medical Cannabis Regulatory Board (a division of the Puerto Rico Department of Health). The Board was created in 2017 under the MEDICINAL Act of 2017 ...
Chuck Hatfield, a Jefferson-City based attorney who is representing the company, said in a statement that the state’s decision was “illegal and unfounded.”
Thirteen of the 14 infractions that cost the maker of popular cannabis brand Muha Meds its manufacturing license last year stemmed from a 2021 raid by the agency that confiscated $30 million in ...
2018: Reflecting the increased growth of support for marijuana legalization, Gallup's annual poll showed that 66% of Americans supported legalization, including 75% of Democrats, 71% of Independents, 59% of people over 55, and at least 65% support in the East, South, Midwest, and West.
ConBud, one of the first businesses fully-licensed to sell recreational cannabis in Manhattan and the first in the city’s Lower East Side, sells various ganja goodies, with prices ranging from ...
While marijuana has been decriminalized throughout many states in the US, it remains a Schedule I drug as of October 2024. However, on January 12, 2024, the FDA announced its recommendation that marijuana be moved to a Schedule III drug, which is a much less strictly-regulated category and would acknowledge its potential for medical use. [67]